Search Within

Ethan Sean Barnett

Formats
  1. Meeting Abstract (19)
  2. Journal Article (10)
  3. Editorial (1)
  4. Review (1)
Groups
  1. Department of Medicine (31)
  2. Genitourinary Oncology Service (31)
  3. Solid Tumor Oncology Division (31)
  4. Hematology-Oncology Fellows (11)
  5. Epidemiology and Biostatistics (10)
  6. GSK Faculty (10)

More Groups

People
  1. Howard Scher (31)
  2. Emily Carbone (23)
  3. Daniel Danila (8)
  4. Wassim Abida (8)
  5. David Solit (7)
  6. Jimmy Zhao (7)

More People

Years
  1. 2023 (3)
  2. 2022 (5)
  3. 2021 (6)
  4. 2020 (10)
  5. 2019 (6)
  6. 2017 (1)
Publications
  1. Journal of Clinical Oncology (14)
  2. Cancer Research (3)
  3. Clinical Cancer Research (3)
  4. Annals of Oncology (2)
  5. European Urology (2)
  6. Clinical Chemistry (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. American Association for Cancer Research (6)
  3. Elsevier Science, Inc. (2)
  4. Oxford University Press (2)
  5. American Association for Clinical Chemistry (1)
  6. American Medical Association (1)

More Publishers

Results (31)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phenotypic circulating tumor cell (CTC) classifier of genomic instability (GI) associates with improved overall survival (OS) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) receiving platinum agents in addition to taxanes
    Meeting Abstract

    Scher, H.; Graf, R. P.; Jendrisak, A.; McLaughlin, B.; Barnett, E.; Schreiber, N. A.; Lee, J.; Kelvin, J.; Wang, Y.; Landers, M.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save